Finally, we hypothesized that greater sleep disruptions and higher OSA severity would be associated with higher PET Aβ and tau burden, lower cognitive performance, more depressed mood symptoms, and the presence of depressive disorder. The gene discussed is MAPT; the disease is obstructive sleep apnea syndrome.